Home CUSTOMERS General Physiology and Biophysics 2023 General Physiology and Biophysics Vol.42, No.4, p. 349–360, 2023

Journal info


Quarterly, 80 pp. per issue
Founded: 1982
ISSN  1338-4325 (online)

Published in English

Aims and Scope
Editorial Info
Abstracting and Indexing
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.


General Physiology and Biophysics Vol.42, No.4, p. 349–360, 2023

Title: BST-1 aggravates aldosterone-induced cardiac hypertrophy via the Ca2+/CaN/NFATc3 pathway
Author: Yao Yuan, Lina Zhao, Hongjuan Cao, Sha Li, Chunyan Liao, Lei Fu, Xing Wang, Fuqin Huang, Weidan Zeng, Aiyue Li, Bei Zhang

Abstract: BST-1 (bone marrow stromal cell antigen-1) is thought to be a key molecule involved in regulating the functional activity of cells in various tissues and organs. BST-1 can catalyze the hydrolysis of nicotinamide adenine dinucleotide (NAD+) to produce cyclic ADP ribose (cADPR), which activates the activity of intracellular Ca2+ signaling. Currently, the role of BST-1 regulation of Ca2+ signaling pathway in pathological myocardial hypertrophy is unclear. We found elevated expression of BST-1 in cardiac hypertrophy tissues of spontaneously hypertensive rats in our vivo study, subsequently; the mechanism of BST-1 action on myocardial hypertrophy was explored in vitro experiment. We used aldosterone (ALD) to induce H9C2 cellular hypertrophy. cADPR levels and intracellular Ca2+ concentrations declined and calcium-regulated neurophosphatase (CaN) activity and protein expression were decreased after BST-1 knockdown. And then activated T-cell nuclear factor (NFATc3) entry nucleus was inhibited. All of the above resulted in that H9C2 cells size was reduced by rhodamine-phalloidin staining. Thus, BST-1 may exacerbate cardiac hypertrophy by activating the Ca2+/CaN/NFATc3 pathway.

Keywords: BST-1 — Cardiac hypertrophy — CaN — NFATc3 — Aldosterone
Published online: 03-Jul-2023
Year: 2023, Volume: 42, Issue: 4 Page From: 349, Page To: 360
doi:10.4149/gpb_2022063


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.